BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7874590)

  • 1. Enhanced hypothalamic-pituitary-adrenocortical axis responses to physostigmine in normal aging.
    Peskind ER; Raskind MA; Wingerson D; Pascualy M; Thal LJ; Dobie DJ; Veith RC; Dorsa DM; Murray S; Sikkema C
    J Gerontol A Biol Sci Med Sci; 1995 Mar; 50(2):M114-20. PubMed ID: 7874590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender.
    Peskind ER; Raskind MA; Wingerson D; Pascualy M; Thal LJ; Dobie DJ; Wilkinson CW
    Biol Psychiatry; 1996 Jul; 40(1):61-8. PubMed ID: 8780856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
    Rubin RT; O'Toole SM; Rhodes ME; Sekula LK; Czambel RK
    Psychiatry Res; 1999 Dec; 89(1):1-20. PubMed ID: 10643873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer disease.
    Asthana S; Raffaele KC; Greig NH; Schapiro MB; Blackman MR; Soncrant TT
    Alzheimer Dis Assoc Disord; 1999; 13(2):102-8. PubMed ID: 10372954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of aging on neuroendocrine responses to physostigmine in normal men.
    Raskind MA; Peskind ER; Veith RC; Wilkinson CW; Federighi D; Dorsa DM
    J Clin Endocrinol Metab; 1990 May; 70(5):1420-5. PubMed ID: 2139880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats.
    Smail MA; Soles JL; Karwoski TE; Rubin RT; Rhodes ME
    Brain Res Bull; 2018 Mar; 137():23-34. PubMed ID: 29122691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic potentiation of the meal-related rise in ACTH and cortisol concentrations in men.
    Dodt C; Hansen K; Uthgenannt D; Born J; Fehm HL
    Exp Clin Endocrinol; 1994; 102(6):460-6. PubMed ID: 7890023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual diergism of hypothalamo-pituitary-adrenal cortical responses to low-dose physotigmine in elderly vs. young women and men.
    Rubin RT; Rhodes ME; O'Toole S; Czambel RK
    Neuropsychopharmacology; 2002 May; 26(5):672-81. PubMed ID: 11927192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic alcohol consumption on the activity of the hypothalamic-pituitary-adrenal axis and pituitary beta-endorphin as a function of alcohol intake, age, and gender.
    Gianoulakis C; Dai X; Brown T
    Alcohol Clin Exp Res; 2003 Mar; 27(3):410-23. PubMed ID: 12658106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In healthy young and elderly adults, hypothalamic-pituitary-adrenocortical axis reactivity (HPA AR) varies with increasing pharmacological challenge and with age, but not with gender.
    Hatzinger M; Brand S; Herzig N; Holsboer-Trachsler E
    J Psychiatr Res; 2011 Oct; 45(10):1373-80. PubMed ID: 21641616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration in normal women and men.
    Rubin RT; Sekula LK; O'Toole S; Rhodes ME; Czambel RK
    Neuropsychopharmacology; 1999 May; 20(5):434-46. PubMed ID: 10192824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of normal aging on cortisol and adrenocorticotropin responses to hypertonic saline infusion.
    Raskind MA; Peskind ER; Pascualy M; Edland SD; Dobie DJ; Murray S; Sikkema C; Wilkinson CW
    Psychoneuroendocrinology; 1995; 20(6):637-44. PubMed ID: 8584604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers.
    Dukoff R; Wilkinson CW; Lasser R; Friz J; Conway A; Bahro M; Peskind ER; Sunderland T
    Biol Psychiatry; 1999 Jul; 46(2):189-95. PubMed ID: 10418693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual diergism in rat hypothalamic-pituitary-adrenal axis responses to cholinergic stimulation and antagonism.
    Rhodes ME; O'Toole SM; Wright SL; Czambel RK; Rubin RT
    Brain Res Bull; 2001 Jan; 54(1):101-13. PubMed ID: 11226719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual diergism of baseline plasma leptin and leptin suppression by arginine vasopressin in major depressives and matched controls.
    Rubin RT; Rhodes ME; Czambel RK
    Psychiatry Res; 2002 Dec; 113(3):255-68. PubMed ID: 12559482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence of pituitary-adrenal cortical hormone responses to low-dose physostigmine administration in young adult women and men.
    Rubin RT; Rhodes ME; Miller TH; Jakab RL; Czambel RK
    Life Sci; 2006 Nov; 79(24):2260-8. PubMed ID: 16935309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free fatty acids exert an inhibitory effect on adrenocorticotropin and cortisol secretion in humans.
    Lanfranco F; Giordano R; Pellegrino M; Gianotti L; Ramunni J; Picu A; Baldi M; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1385-90. PubMed ID: 15001638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
    Buckley TM; Mullen BC; Schatzberg AF
    Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrous cycle influences on sexual diergism of HPA axis responses to cholinergic stimulation in rats.
    Rhodes ME; Balestreire EM; Czambel RK; Rubin RT
    Brain Res Bull; 2002 Nov; 59(3):217-25. PubMed ID: 12431752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.